BD, a leading global medical technology company, announced today that it signed a definitive agreement to acquire Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company that develops and ...
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global technology company, today announced the completion of its acquisition of Accuri Cytometers, Inc., an Ann Arbor, Michigan-based company ...
BD Biosciences, a segment of BD (Becton, Dickinson and Company) has announced the U.S clearance and release of the BD FACSCanto™ II flow cytometry system for in vitro diagnostic (IVD) use. This ...
FRANKLIN LAKES, N.J. & SAN DIEGO, January 23, 2025--(BUSINESS WIRE)--BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of laboratory ...
BD FACSDuet™ Sample Preparation System, now available in the U.S., as the first fully automated sample-to-answer solution when integrated with the BD FACSLyric™ Flow Cytometer FRANKLIN LAKES, N.J., ...
Becton, Dickinson and CompanyBDX, more commonly known as BD, introduced BD FACSCelesta flow cytometer at the recent 2015 American Society for Cell Biology annual meeting. The solution is primarily ...
Franklin Lakes, N.J.-based Becton Dickinson and Co. (NYSE: BDX) said Monday that it had signed a definitive agreement to acquire Accuri Cytometers Inc., an Ann Arbor-based company that develops and ...
Company will focus on expanding the use of Accuri’s C6 Flow Cytometer. BD signed an agreement to acquire Accuri Cytometers, broadening its presence in the flow cytometer space. BD says that it will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback